Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,964,785
-
Share change
-
-617,357
-
Total reported value
-
$165,632,209
-
Put/Call ratio
-
64%
-
Price per share
-
$7.55
-
Number of holders
-
75
-
Value change
-
-$3,060,083
-
Number of buys
-
34
-
Number of sells
-
32
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q3 2018
As of 30 Sep 2018,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,964,785 shares.
The largest 10 holders included
BlackRock Inc., Knoll Capital Management, LP, Vanguard Group Inc, FMR LLC, IFP Advisors, Inc, MORGAN STANLEY, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and Raymond James Financial Services Advisors, Inc..
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.